{
  "url": "https://openlegislation.uk/veterinary-medicines-regulations-2006/schedule-7/paragraph-8",
  "json_url": "https://openlegislation.uk/veterinary-medicines-regulations-2006/schedule-7/paragraph-8.json",
  "legislation": "uksi/2006/2407",
  "legislation_title": "The Veterinary Medicines Regulations 2006",
  "legislation_url": "https://openlegislation.uk/veterinary-medicines-regulations-2006",
  "path": "schedule/7/paragraph/8",
  "kind": "paragraph",
  "number": "8",
  "heading": "Application for a marketing authorisation for an immunological product",
  "text": "(1) The fee for a national application for a marketing authorisation relating to an immunological product, a decentralised application where the United Kingdom is the concerned member State or the mutual recognition of a product authorised in another member State is in accordance with the following table.\nFees for specified immunological applications\nMenu\nNational application for a marketing authorisation (£)\nDecentralised application where the UK is a concerned member State or recognition of a product authorised in another member State (£)\nBase fee:\n11,310\n5,560\nThe following fees are in addition to the base fee—\nAdditional fee for each active ingredient not previously included in a veterinary medicinal product authorised in the United Kingdom, and for each new combination of active ingredients:\n7,100\n2,390\nAdditional fee for each adjuvant or preservative not previously included in a veterinary medicinal product authorised in the United Kingdom and for each new combination of adjuvants or preservatives:\n1,300\n640\nMore than one antigenic component—fee for each additional component:\n1,290\n390\nMore than one species—fee for each additional species:\n5,170\n1,550\nMore than one route of administration—fee for each additional route of administration:\n5,170\n1,550\nSimultaneous application—fee for each additional product in the application:\n2,780\n1,610\n(2) The fee for an application for a marketing authorisation for an immunological product that is identical to a product already authorised in the United Kingdom but with a lesser number of antigens and which only contains antigens contained in the product already authorised is £10,020 (United Kingdom only) or £5,170 (decentralised application where the United Kingdom is a concerned member State).",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 7 para. 8 in force at 1.10.2006, see reg. 1"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2006/2407/schedule/7/paragraph/8",
    "retrieved_at": "2026-10-29T04:22:09.984208+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}